Gene expression alterations of TRIP13, CDKN3, FBXO43, SPDL1 and E2F1 have been reported in HCC and these genes were proposed as prognostic markers or therapeutic targets for HCC patients [50–55]. Here, E2F1 is linked to hepatocellular carcinoma.